Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-008130

EVP, Chief Medical Officer sold 1,704 shares at $9.86 ($16,805)

From the SEC's structured data for this filing

Trades in this filing

Shah Jatin · EVP, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-07 Sale : show line 1 in the form −1,704 $9.86 $16,805 130,756 D
Open-market sales · 1,704 sh · avg $9.86 · $16,805
Loading xslF345X03/doc4.xml…